Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

The peripheral blood compartment in patients with Graves' disease: activated T lymphocytes and increased transitional and pre-naive mature B lymphocytes.

Van der Weerd K, Van Hagen PM, Schrijver B, Kwekkeboom DJ, De Herder WW, Ten Broek MR, Postema PT, Van Dongen JJ, Staal FJ, Dik WA.

Clin Exp Immunol. 2013 Nov;174(2):256-64. doi: 10.1111/cei.12183.

3.
6.

Correlation of activated monocytes or B cells with T lymphocyte subsets in patients with Graves' disease.

González A, Calleja A, Santiago E, De Miguel C, López-Zabalza MJ, López-Moratalla N.

Int J Mol Med. 1998 Jan;1(1):95-103.

PMID:
9852205
7.

Analysis of IL-2 and IL-6 binding to peripheral blood lymphocytes in Graves disease: relationship with disease activity.

Corrales JJ, Orfao A, López A, Mories MT, Miralles JM, Ciudad J.

Cytometry. 1997 Jun 15;30(3):118-23.

PMID:
9222097
8.
10.

Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland.

Bisset LR, Lung TL, Kaelin M, Ludwig E, Dubs RW.

Eur J Haematol. 2004 Mar;72(3):203-12.

PMID:
14962239
11.

CD5+ B cells in Graves' disease: correlation with disease activity.

Corrales JJ, Orfao A, López A, Mories MT, Miralles JM, Ciudad J.

Horm Metab Res. 1996 Jun;28(6):280-5.

PMID:
8811329
12.
13.

Age dependency and mutual relations in T and B lymphocyte abnormalities in common variable immunodeficiency patients.

Vlková M, Thon V, Sárfyová M, Bláha L, Svobodník A, Lokaj J, Litzman J.

Clin Exp Immunol. 2006 Feb;143(2):373-9.

14.

Characterization of lymphoid cells in the thyroid of patients with Graves' disease.

Warford A, McLachlan SM, Malcolm AJ, Young ET, Farndon JR, Rees Smith B.

Clin Exp Immunol. 1984 Sep;57(3):626-32.

15.

[Circulating HLA-DR (Ia) positive T cells and T cell activation by thyroglobulin, thyroid microsome and TSH-receptor in autoimmune thyroid diseases].

Zeki K, Fujihira T, Shirakawa F, Watanabe K, Eto S.

Nihon Naibunpi Gakkai Zasshi. 1987 Jun 20;63(6):719-26. Japanese.

PMID:
3499354
17.

Serial analysis of the effects of methimazole therapy on circulating B cell subsets in Graves' disease.

Corrales JJ, Orfao A, López A, Ciudad J, Mories MT.

J Endocrinol. 1996 Nov;151(2):231-40.

PMID:
8958783
18.

Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells.

Corrales JJ, López A, Ciudad J, Mories MT, Miralles JM, Orfao A.

J Endocrinol. 1997 Dec;155(3):491-500.

19.

Expression of adhesion molecules on infiltrating T cells in thyroid glands from patients with Graves' disease.

Ishikawa N, Eguchi K, Ueki Y, Nakashima M, Shimada H, Ito K, Nagataki S.

Clin Exp Immunol. 1993 Nov;94(2):363-70.

20.

HLA-DR antigen expression on intrathyroidal lymphocytes and thyrocytes in Hashimoto's thyroiditis and Graves' disease: an immunohistological study.

Misaki T, Konishi J, Arai K, Iida Y, Kasagi K, Kuma K, Torizuka K.

Endocrinol Jpn. 1987 Apr;34(2):257-62.

Supplemental Content

Support Center